Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

Tune in for today's full episode of Few &amp; Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

Episode 9:  Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Science

Medicine

Health & Fitness

Mental Health

Life Sciences

Welcome to Few &amp; Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Share Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Sign up to save your podcasts

Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

More shows like Few & Far Between: Conversations from the Front Lines of Drug Development

The Readout Loud